IVEG members and other KOLS express their professional views on different aspects of retinal pathologies and intravitreal injection therapy. Including highlights from major ophthalmology meetings.

What are the benefits of using aflibercept with a proactive, T&E approach in AMD? Two experts sp

LEARN MORE

Expert comments on the 6-month results of the APOLLON study, investigating the real-world outcomes o

LEARN MORE

Two-year follow-up of real world outcomes of intravitreal aflibercept

LEARN MORE

Jordi Monés, MD, PhD. Several agents combined with anti-VEGFs have not met expectations

LEARN MORE
Older »

There are no more Expert Perspective content.

Error